Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
641 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01887522 | Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults(VINILO) | terminated | Phase 2 | 144 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 8 | May 31, 2022 | clinicaltrials |
| NCT00887783 | Navelbine And Radiotherapy in Locally Advanced Lung Cancer(NARLAL) | completed | Phase 2 | 117 | Odense University HospitalOTHER | 1 | May 17, 2022 |
| clinicaltrials |
| NCT04609215 | ImmunoBreast - A Phase Ib Study | unknown | Phase 1 / Phase 2 | 20 | Henrik DitzelOTHER | 1 | Apr 20, 2022 | clinicaltrials |
| NCT03850522 | PD-L1 Peptide Vaccination in High Risk Smoldering Multiple Myeloma | terminated | Phase 2 | 6 | Lene Meldgaard KnudsenOTHER | 1 | Apr 15, 2022 | clinicaltrials |
| NCT03541252 | Topical Laser-assisted Combination Chemotherapy for Basal Cell Carcinoma- a Clinical Study | completed | Phase 1 / Phase 2 | 20 | Merete HaedersdalOTHER | 1 | Apr 14, 2022 | clinicaltrials |
| NCT04258150 | Ipilimumab, Nivolumab, Tocilizumab and Radiation in Pretreated Patients With Advanced Pancreatic Cancer(TRIPPLE-R) | terminated | Phase 2 | 26 | Herlev HospitalOTHER | 1 | Mar 31, 2022 | clinicaltrials |
| NCT05289336 | DAHANCA 27 Transoral Laser Microsurgery for T1a Glottic Cancer(DAHANCA 27) | unknown | Phase 2 | 80 | Danish Head and Neck Cancer GroupNETWORK | 1 | Mar 21, 2022 | clinicaltrials |
| NCT04835402 | Electroporation Potentiated Immunotherapy in Cancer(EPIC-1) | unknown | Phase 2 | 8 | Ole Thorlacius-Ussing, MD, DMSc, Professor of SurgeryOTHER | 1 | Mar 9, 2022 | clinicaltrials |
| NCT03359681 | Metformin Treatment for Colon Cancer(MECORA) | completed | Phase 2 | 48 | Zealand University HospitalOTHER | 1 | Mar 3, 2022 | clinicaltrials |
| NCT04167436 | Fit for Surgery. Multimodal Prehabilitation in Colorectal Cancer Patients | unknown | Phase 2 / Phase 3 | 48 | Zealand University HospitalOTHER | 1 | Mar 3, 2022 | clinicaltrials |
| NCT05220800 | Effects of Intravenous Administered Iron in Non-anemic Iron Deficient Patients With Colorectal Cancer(NAIDIC) | not yet recruiting | Phase 2 | 134 | Zealand University HospitalOTHER | 1 | Mar 3, 2022 | clinicaltrials |
| NCT04247256 | A Phase 2 Trial of SCO-101 in Combination With FOLFIRI for Patients With Metastatic Colorectal Cancer (mCRC) With Acquired Resistance to FOLFIRI | unknown | Phase 1 / Phase 2 | 35 | Scandion Oncology A/SINDUSTRY | 3 | Mar 2, 2022 | clinicaltrials |
| NCT03748680 | IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer(IMPROVE-IT) | unknown | Phase 2 | 64 | Karen-Lise Garm SpindlerOTHER | 1 | Feb 25, 2022 | clinicaltrials |
| NCT01861496 | Phase I/II Study to Evaluate the Safety and Tolerability of LiPlaCis in Patients With Advanced or Refractory Tumours(LiPlaCis) | completed | Phase 1 / Phase 2 | 50 | Allarity TherapeuticsINDUSTRY | 1 | Feb 24, 2022 | clinicaltrials |
| NCT03939234 | Peptide Vaccination With PD-L1 and PD-L2 Peptides in Untreated Chronic Lymphatic Leukemia. | completed | Phase 2 | 19 | Lars Møller PedersenOTHER | 1 | Feb 21, 2022 | clinicaltrials |
| NCT04541290 | Tacrolimus as Treatment of Breast Cancer-Related Lymphedema | completed | Phase 1 / Phase 2 | 20 | Odense University HospitalOTHER | 1 | Feb 9, 2022 | clinicaltrials |
| NCT05164393 | Phase I/IIa Trial to Evaluate AVX001 Gel in Doses of 1% or 3% Compared With Vehicle Over Four Weeks of Field-directed Treatment Period in Adult Subjects With AK(COAKS) | unknown | Phase 1 / Phase 2 | 60 | Coegin Pharma ABINDUSTRY | 1 | Jan 27, 2022 | clinicaltrials |
| NCT03715985 | Personalized Neo-antigen Vaccine in Advanced Solid Tumors (NeoPepVac)(NeoPepVac) | unknown | Phase 1 / Phase 2 | 12 | Herlev HospitalOTHER | 1 | Jan 11, 2022 | clinicaltrials |
| NCT02001623 | Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 195 | Seagen Inc.INDUSTRY | 5 | Dec 29, 2021 | clinicaltrials |
| NCT04652206 | Clinical Trial to Investigate Safety, Tolerability and MTD for SCO-101 in Combination With Gemcitabine and Nab-paclitaxel in Inoperable Pancreatic Cancer Patients.(PANTAX-Ib) | unknown | Phase 1 / Phase 2 | 18 | Scandion Oncology A/SINDUSTRY | 2 | Dec 29, 2021 | clinicaltrials |
| NCT03668639 | Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin | unknown | Phase 2 / Phase 3 | 80 | Christina RuhlmannOTHER | 1 | Dec 14, 2021 | clinicaltrials |
| NCT01677741 | A Study to Determine Safety, Tolerability and Pharmacokinetics of Oral Dabrafenib In Children and Adolescent Subjects | completed | Phase 1 / Phase 2 | 85 | Novartis PharmaceuticalsINDUSTRY | 10 | Nov 24, 2021 | clinicaltrials |
| NCT04585620 | Botulinum Toxin A as Treatment for Chronic Postsurgical Pain Following Lung Cancer Surgery | unknown | Phase 1 / Phase 2 | 30 | Allan Vestergaard Danielsen, MDOTHER | 1 | Nov 9, 2021 | clinicaltrials |
| NCT00865969 | Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma(PTCL) | completed | Phase 2 | 129 | Spectrum Pharmaceuticals, IncINDUSTRY | 17 | Oct 29, 2021 | clinicaltrials |
| NCT04430985 | FOLFOX + Immunotherapy With Intrahepatic Oxaliplatin for Patients With Metastatic Colorectal Cancer(IMMUNOX) | withdrawn | Phase 2 | 0 | Dorte NielsenOTHER | 1 | Oct 27, 2021 | clinicaltrials |
| NCT03890744 | ModraDoc006/r in Patients With Breast Cancer | completed | Phase 2 | 12 | Modra PharmaceuticalsINDUSTRY | 3 | Oct 19, 2021 | clinicaltrials |
| NCT03505944 | Venetoclax, Lenalidomide and Rituximab in Patients With Relapsed/Refractory Mantle Cell Lymphoma(VALERIA) | unknown | Phase 1 / Phase 2 | 59 | Nordic Lymphoma GroupNETWORK | 4 | Oct 13, 2021 | clinicaltrials |
| NCT03576443 | Trial of Idelalisib in Patients With Relapsed Diffuse Large B-cell Lymphoma(ILIAD) | completed | Phase 2 | 36 | Nordic Lymphoma GroupNETWORK | 2 | Oct 13, 2021 | clinicaltrials |
| NCT04114825 | Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer(BRaVac) | active not recruiting | Phase 2 | 180 | RhoVac APSINDUSTRY | 7 | Sep 28, 2021 | clinicaltrials |
| NCT05055635 | Pencil Beam Proton Therapy for Recurrences in Anal Cancer Patients Previously Treated With Radiotherapy (DACG 5)(ReRad III) | recruiting | Phase 2 | 55 | University of AarhusOTHER | 1 | Sep 24, 2021 | clinicaltrials |
| NCT05038007 | Pain After Lung Cancer Surgery - Comparing Traditional Versus Prolonged Release Nerve Blockades | unknown | Phase 2 | 50 | Jannie Bisgaard StæhrOTHER | 1 | Sep 21, 2021 | clinicaltrials |
| NCT03716583 | Melatonin Cream Against Acute Radiation Dermatitis in Patients With Early Breast Cancer(MELADERM) | completed | Phase 2 | 48 | Dennis Bregner ZetnerOTHER | 1 | Sep 10, 2021 | clinicaltrials |
| NCT03136653 | A Phase 2 Trial of MP0250 Plus Bortezomib + Dexamethasone in Patients With Multiple Myeloma | completed | Phase 1 / Phase 2 | 33 | Molecular Partners AGINDUSTRY | 6 | Aug 25, 2021 | clinicaltrials |
| NCT02106312 | Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcomas(DOREMY) | unknown | Phase 2 | 80 | The Netherlands Cancer InstituteOTHER | 5 | Aug 4, 2021 | clinicaltrials |
| NCT03052751 | Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis | completed | Phase 2 | 43 | UCB Biopharma S.P.R.L.INDUSTRY | 7 | Aug 3, 2021 | clinicaltrials |
| NCT00109707 | A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies | completed | Phase 1 / Phase 2 | 507 | Novartis PharmaceuticalsINDUSTRY | 22 | Jun 29, 2021 | clinicaltrials |
| NCT03776721 | Treatment of Breast Cancer-related Lymphedema With Stem Cells and Fat Grafting | completed | Phase 2 | 80 | Odense University HospitalOTHER | 1 | Jun 25, 2021 | clinicaltrials |
| NCT04390685 | Prevention of Breast Cancer-related Lymphedma With Tacrolimus(BCRL-TACRO) | unknown | Phase 1 / Phase 2 | 60 | Odense University HospitalOTHER | 1 | Jun 25, 2021 | clinicaltrials |
| NCT02458638 | A Study of Atezolizumab in Advanced Solid Tumors | completed | Phase 2 | 474 | Hoffmann-La RocheINDUSTRY | 18 | Jun 4, 2021 | clinicaltrials |
| NCT02909751 | Tocotrienol in Combination With Neoadjuvant Chemotherapy for Women With Breast Cancer(NeoToc) | completed | Phase 2 | 80 | Vejle HospitalOTHER | 1 | May 20, 2021 | clinicaltrials |
| NCT02552121 | Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 33 | Seagen Inc.INDUSTRY | 5 | Apr 8, 2021 | clinicaltrials |
| NCT01563354 | 3-arm Trial to Evaluate Pasireotide LAR/Everolimus Alone/in Combination in Patients With Lung/Thymus NET - LUNA Trial(LUNA) | completed | Phase 2 | 124 | Novartis PharmaceuticalsINDUSTRY | 9 | Apr 2, 2021 | clinicaltrials |
| NCT04495010 | Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Nivolumab or Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Observation Compared With Adjuvant Nivolumab in Treatment-Naive High-risk Melanoma Participants(CheckMate 7UA) | withdrawn | Phase 2 | 0 | Bristol-Myers SquibbINDUSTRY | 16 | Mar 19, 2021 | clinicaltrials |
| NCT02372006 | Trial of Afatinib in Pediatric Tumours | completed | Phase 1 / Phase 2 | 56 | Boehringer IngelheimINDUSTRY | 12 | Mar 4, 2021 | clinicaltrials |
| NCT01783444 | A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer.(BOLERO-6) | completed | Phase 2 | 309 | Novartis PharmaceuticalsINDUSTRY | 18 | Feb 26, 2021 | clinicaltrials |
| NCT02404389 | Safety, Tolerability, and Efficacy Study of LFX453 in Actinic Keratosis Patients | completed | Phase 2 | 82 | Novartis PharmaceuticalsINDUSTRY | 5 | Jan 5, 2021 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials